XRAYBAX LIMITED
No Analysis Available
Get instant AI-powered insights about this company's financial health, risks, and trends.
Order Analysis - £10Company Documents
Date | Description |
---|---|
20/01/2520 January 2025 | Total exemption full accounts made up to 2024-09-30 |
30/09/2430 September 2024 | Annual accounts for year ending 30 Sep 2024 |
25/09/2425 September 2024 | Confirmation statement made on 2024-09-25 with updates |
12/03/2412 March 2024 | Total exemption full accounts made up to 2023-09-30 |
20/02/2420 February 2024 | Change of details for Dr Andrew Duncan Baxter as a person with significant control on 2019-09-26 |
19/02/2419 February 2024 | Director's details changed for Dr Andrew Duncan Baxter on 2019-09-26 |
11/10/2311 October 2023 | Confirmation statement made on 2023-09-25 with updates |
30/09/2330 September 2023 | Annual accounts for year ending 30 Sep 2023 |
23/03/2323 March 2023 | Micro company accounts made up to 2022-09-30 |
27/10/2227 October 2022 | Confirmation statement made on 2022-09-25 with no updates |
30/09/2230 September 2022 | Annual accounts for year ending 30 Sep 2022 |
30/09/2130 September 2021 | Annual accounts for year ending 30 Sep 2021 |
28/09/2128 September 2021 | Confirmation statement made on 2021-09-25 with no updates |
15/04/2115 April 2021 | MICRO COMPANY ACCOUNTS MADE UP TO 30/09/20 |
01/10/201 October 2020 | CONFIRMATION STATEMENT MADE ON 25/09/20, NO UPDATES |
30/09/2030 September 2020 | Annual accounts for year ending 30 Sep 2020 |
26/09/1926 September 2019 | CERTIFICATE OF INCORPORATION GENERAL COMPANY DETAILS & STATEMENTS OF; OFFICERS, CAPITAL & SHAREHOLDINGS, GUARANTEE, COMPLIANCE MEMORANDUM OF ASSOCIATION ARTICLES OF ASSOCIATION |
More Company Information
Recently Viewed
Follow Company
- Receive an alert email on changes to financial status
- Early indications of liquidity problems
- Warns when company reporting is overdue
- Free service, no spam emails Follow this company